Nuvation Bio Balance Sheet Health

Financial Health criteria checks 5/6

Nuvation Bio has a total shareholder equity of $532.1M and total debt of $11.6M, which brings its debt-to-equity ratio to 2.2%. Its total assets and total liabilities are $594.8M and $62.7M respectively.

Key information

2.2%

Debt to equity ratio

US$11.63m

Debt

Interest coverage ration/a
CashUS$577.17m
EquityUS$532.13m
Total liabilitiesUS$62.67m
Total assetsUS$594.80m

Recent financial health updates

Recent updates

Nuvation Bio: Competitive Data In ROS1+ NSCLC, Strong Cash, Smallish Market

Oct 21

Nuvation Bio: Continuing To Justify A Buy Thesis With Catalysts In 2024

Aug 08

Is Nuvation Bio (NYSE:NUVB) A Risky Investment?

Aug 07
Is Nuvation Bio (NYSE:NUVB) A Risky Investment?

Nuvation Bio: A Potentially Transformative Acquisition

Jun 20

Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate

Mar 31

Nuvation: Cash Is King, Science Is An Afterthought

Oct 03

We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth

Sep 14
We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth

Seth Klarman's Baupost adds Herbalife, Altice USA, exits Dropbox, Enhabit

Feb 14

We're Hopeful That Nuvation Bio (NYSE:NUVB) Will Use Its Cash Wisely

Feb 10
We're Hopeful That Nuvation Bio (NYSE:NUVB) Will Use Its Cash Wisely

We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth

Nov 09
We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth

Nuvation Bio GAAP EPS of -$0.12 beats by $0.02

Nov 03

Financial Position Analysis

Short Term Liabilities: NUVB's short term assets ($587.2M) exceed its short term liabilities ($51.1M).

Long Term Liabilities: NUVB's short term assets ($587.2M) exceed its long term liabilities ($11.6M).


Debt to Equity History and Analysis

Debt Level: NUVB has more cash than its total debt.

Reducing Debt: NUVB's debt to equity ratio has increased from 0.5% to 2.2% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NUVB has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: NUVB has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 24.6% each year


Discover healthy companies